衰退の治療のための粘膜歯科手術における抗生物質:ナラティブレビュー

Magdalena Latkowska-Wiśniewska¹, Sylwia Jakubowska¹, Bartłomiej Górski¹

¹Department of Periodontology and Oral Mucosa Diseases, Medical University of Warsaw, Binieckiego 6 St., 02-097 Warsaw, Poland.

Antibiotics (Basel, Switzerland)

|August 28, 2025

まとめ

通常の全身抗生物質治療は,歯周回転手術を受けるほとんどの患者には推奨されません. 予防用抗生物質は,感染性心内炎や免疫不全などの高リスクの個人にのみ投与されます.

科学分野:

歯周病学
口腔外科
抗生物質の管理

背景:

歯周病は口腔の健康と美学に悪影響を及ぼします
根を覆う手術は歯周病の標準治療法です
これらの手順における全身性抗生物質の役割は明確化が必要です.

研究の目的:

陰茎の衰退の治療における全身抗生物質療法の必要性と有効性を批判的に評価する.
歯周矯正手術における抗生物質の使用に関する臨床医のための根拠に基づいたガイドラインを提供すること.

主な方法:

既存の科学文献の記述的なレビュー
景気後退をカバーする手順における抗生物質の使用を調査する研究の分析
現在の証拠と臨床ガイドラインの統合

主要な成果:

現行の文献は,衰退カバー手術を受ける全身的に健康な患者の全身性抗生物質の日常的な使用を支持していません.
予防用抗生物質の投与は,特定の高リスク患者グループ (例えば,感染性心内炎のリスク,免疫低下患者) に限られています.
膜手術では,適切な無菌技術と手術前の組織準備によって,低感染リスクが達成可能である.

結論:

健康な患者では,通常の歯周回転手術では,全身の抗生物質療法は通常推奨されません.
抗生物質の使用に関する臨床的決定は,患者の健康状態と現在のガイドラインに基づいて個別化されなければならない.
抗生物質が景気後退に及ぼす影響を決定的に評価するには,さらなる見通し研究が必要である.

キーワード:

抗菌剤抗生物質による予防バクテリア結合組織移植薬剤耐性歯茎の衰退ムコジンギバル手術外科傷口感染症傷が治る

さらに関連する動画

06:14

Induction of Periodontitis via a Combination of Ligature and Lipopolysaccharide Injection in a Rat Model

Published on: February 17, 2023

4.3K

05:37

Experimental Model of Ligature-Induced Peri-Implantitis in Mice

Published on: May 17, 2024

2.5K

関連する概念動画

01:26

Tonsillitis II: Management

174

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

174

01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

546

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

546

01:26

Peptic Ulcer Disease IV: Management

145

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

145

01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

684

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

684

01:21

Inflammatory Bowel Disease V: Surgical Management

206

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

206

01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

406

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

406

関連する実験動画